Harmonization of pipeline for detection of HFOs in a rat model of post-traumatic epilepsy in preclinical multicenter study on post-traumatic epileptogenesis.


Journal

Epilepsy research
ISSN: 1872-6844
Titre abrégé: Epilepsy Res
Pays: Netherlands
ID NLM: 8703089

Informations de publication

Date de publication:
10 2019
Historique:
received: 23 12 2018
revised: 12 03 2019
accepted: 14 03 2019
pubmed: 15 4 2019
medline: 23 7 2020
entrez: 15 4 2019
Statut: ppublish

Résumé

Studies of chronic epilepsy show pathological high frequency oscillations (HFOs) are associated with brain areas capable of generating epileptic seizures. Only a few of these studies have focused on HFOs during the development of epilepsy, but results suggest pathological HFOs could be a biomarker of epileptogenesis. The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy" (EpiBioS4Rx) is a multi-center project designed to identify biomarkers of epileptogenesis after a traumatic brain injury (TBI) and evaluate treatments that could modify or prevent the development of post-traumatic epilepsy. One goal of the EpiBioS4Rx project is to assess whether HFOs could be a biomarker of post-traumatic epileptogenesis. The current study describes the work towards this goal, including the development of common surgical procedures and EEG protocols, an interim analysis of the EEG for HFOs, and identifying issues that need to be addressed for a robust biomarker analysis. At three participating sites - University of Eastern Finland (UEF), Monash University in Melbourne (Melbourne) and University of California, Los Angeles (UCLA) - TBI was induced in adult male Sprague-Dawley rats by lateral fluid-percussion injury. After injury and in sham-operated controls, rats were implanted with screw and microwire electrodes positioned in neocortex and hippocampus to record EEG. A separate group of rats had serial magnetic resonance imaging after injury and then implanted with electrodes at 6 months. Recordings 28 days post-injury were available from UEF and UCLA, but not Melbourne due to technical issues with their EEG files. Analysis of recordings from 4 rats - UEF and UCLA each had one TBI and one sham-operated control - showed EEG contained evidence of HFOs. Computer-automated algorithms detected a total of 1,819 putative HFOs and of these only 40 events (2%) were detected by all three sites. Manual review of all events verified 130 events as HFO and the remainder as false positives. Review of the 40 events detected by all three sites was associated with 88% agreement. This initial report from the EpiBioS4Rx Consortium demonstrates the standardization of EEG electrode placements, recording protocol and long-term EEG monitoring, and differences in detection algorithm HFO results between sites. Additional work on detection strategy, detection algorithm performance, and training in HFO review will be performed to establish a robust, preclinical evaluation of HFOs as a biomarker of post-traumatic epileptogenesis.

Identifiants

pubmed: 30981541
pii: S0920-1211(18)30612-0
doi: 10.1016/j.eplepsyres.2019.03.008
pmc: PMC6736751
mid: NIHMS1526794
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

106110

Subventions

Organisme : NINDS NIH HHS
ID : P20 NS080181
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS100064
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Références

Epilepsia. 2000;41 Suppl 6:S144-52
pubmed: 10999536
Epilepsia. 2004 Sep;45(9):1017-23
pubmed: 15329064
J Neurotrauma. 2006 Feb;23(2):241-61
pubmed: 16503807
Epilepsia. 2007;48 Suppl 5:35-40
pubmed: 17910579
Neurobiol Dis. 2011 Jun;42(3):231-41
pubmed: 21238589
Prog Neurobiol. 2012 Sep;98(3):250-64
pubmed: 22420980
Prog Neurobiol. 2012 Sep;98(3):302-15
pubmed: 22480752
J Clin Neurophysiol. 2015 Jun;32(3):207-19
pubmed: 26035673
Clin Neurophysiol. 2016 Jan;127(1):187-196
pubmed: 26100149
Epilepsia. 2015 Dec;56(12):1879-89
pubmed: 26514993
PLoS One. 2016 Jun 24;11(6):e0158276
pubmed: 27341033
Clin Neurophysiol. 2017 Mar;128(3):433-441
pubmed: 28160749
Epilepsia. 2017 Aug;58(8):1330-1339
pubmed: 28681378
Clin Neurophysiol. 2018 Oct;129(10):2089-2098
pubmed: 30077870
N Engl J Med. 1998 Jan 1;338(1):20-4
pubmed: 9414327

Auteurs

Cesar Santana-Gomez (C)

Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: csantanagomez@mednet.ucla.edu.

Pedro Andrade (P)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Matthew R Hudson (MR)

The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, VIC, 3052, Australia.

Tomi Paananen (T)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Robert Ciszek (R)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Gregory Smith (G)

Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Idrish Ali (I)

The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, VIC, 3052, Australia.

Brian K Rundle (BK)

Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Xavier Ekolle Ndode-Ekane (XE)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Pablo M Casillas-Espinosa (PM)

The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, VIC, 3052, Australia.

Riikka Immonen (R)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Noora Puhakka (N)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Nigel Jones (N)

The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, VIC, 3052, Australia.

Rhys D Brady (RD)

The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, VIC, 3052, Australia.

Piero Perucca (P)

The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, VIC, 3052, Australia.

Sandy R Shultz (SR)

The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, VIC, 3052, Australia.

Asla Pitkänen (A)

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.

Terence J O'Brien (TJ)

The Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, VIC, 3052, Australia.

Richard Staba (R)

Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH